Ascent PharmaTech Co., Ltd. 2025 Q4 Financials
NQ Score
57/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Ascent PharmaTech Co., Ltd. reported a basic EPS of NTbash.90 for Q4 2025. The company's operating revenue reached NT.344 billion, with a net income after tax of NTbash.107 billion.
AI analysis data is not yet available.